SRT1720 claim as an activator of SIRT1 has been refuted

edit

Please see Pfizer's well recieved peer reviewed journal article refuting Sirtris' claims. In a nutshell, 1. Apparent activation of the enzyme is shown clearly to be a "non-natural substrate specific" artifact of the assay system. 2. Animal study results could not be reproduced with severe adverse effects of the compounds noted at high doses.

[1]

Tom McDonagh

74.9.55.102 (talk) 02:20, 13 January 2010 (UTC)Reply

References